AKTX: Akari Therapeutics Plc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-12 | New 13G stake | Bank of Montreal | 5.71% | SEC | |
| 2026-08-07 | New 13G stake | White Lion Capital LLC | 5.00% | SEC |
Institutional ownership (Q2 2026)
9 institutions reported holding $1.40M of Akari Therapeutics Plc on Form 13F (6 the quarter before). 5 opened a new position and 2 sold out. Shares held by institutions: +151%.
| Largest holders | Shares | Value |
|---|---|---|
| MMCAP International Inc. SPC | 100,000 | $1.02M |
| Cresset Asset Management, LLC | 20,561 | $211K |
| JANE STREET GROUP, LLC | 15,463 | $158K |
| IFP Advisors, Inc | 181 | $2K |
| SBI Securities Co., Ltd. | 14 | $143 |
| HRT FINANCIAL LP | 13,745 | $140 |
| Caitong International Asset Management Co., Ltd | 8 | $82 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 7 | $72 |
| Truvestments Capital LLC | 1 | $10 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.